iGEN
Visit IGEN World Explore IGEN Expo
EXPLORE UPGRADE PLANS
BREAKING
New Senate bill targets 'chameleon carriers' that reopen to escape penalties Werner Enterprises Posts Highest Revenue Per Truck Growth in One-Way Segment in a Decade CMA CGM and Stonepeak Launch United Ports LLC in $2.4 Billion Terminal Joint Venture UPS shift away from Amazon shows bigger payoff Lanesurf: 62% of Loads Get Vetted Carrier Offers Before Brokers Arrive India-China Border Trade Via Lipulekh Resumes Aug 1; China Permits 20 Traders Geopolitics Drives CMA CGM Q2 Profit Surge of 42% as Volumes and Rates Climb Benchmark Diesel Price Rises Third Week as Futures Plunge; Spread Hits Record Indian Government Limits Sugar Dealers to 400 Tonnes Stock Until November to Curb Hoarding Tenants signing longer leases for larger warehouses as 3PLs lock in capacity New Senate bill targets 'chameleon carriers' that reopen to escape penalties Werner Enterprises Posts Highest Revenue Per Truck Growth in One-Way Segment in a Decade CMA CGM and Stonepeak Launch United Ports LLC in $2.4 Billion Terminal Joint Venture UPS shift away from Amazon shows bigger payoff Lanesurf: 62% of Loads Get Vetted Carrier Offers Before Brokers Arrive India-China Border Trade Via Lipulekh Resumes Aug 1; China Permits 20 Traders Geopolitics Drives CMA CGM Q2 Profit Surge of 42% as Volumes and Rates Climb Benchmark Diesel Price Rises Third Week as Futures Plunge; Spread Hits Record Indian Government Limits Sugar Dealers to 400 Tonnes Stock Until November to Curb Hoarding Tenants signing longer leases for larger warehouses as 3PLs lock in capacity
Home ›› Topics ›› ozempic

Topic

ozempic

2 stories
Ozempic-maker Novo Nordisk sues Eli Lilly for false advertising over weight-loss drug claims Manufacturing
Pharmaceuticals #novo nordisk#eli lilly

Ozempic-maker Novo Nordisk sues Eli Lilly for false advertising over weight-loss drug claims

Novo Nordisk has sued Eli Lilly, alleging false advertising in Eli Lilly's campaigns that compare weight-loss and diabetes drugs. Novo claims Eli Lilly intentionally used outdated studies and omitted higher-dose options to create a misleading impression of superiority. The lawsuit seeks to pull the ads and run corrective advertising.

Jul 21, 2026 1 source
Just About Anyone Can Sell GLP-1s Online Now: Turnkey Telehealth Sparks Market Flood Manufacturing
Pharmaceuticals #glp-1#ozempic

Just About Anyone Can Sell GLP-1s Online Now: Turnkey Telehealth Sparks Market Flood

The rise of turnkey telehealth services is enabling companies with no medical background—from search platforms like JustAnswer to dating apps like Grindr—to sell GLP-1 drugs online. Infrastructure firms handle software, clinician networks, and compliance, allowing new entrants to launch in as little as three hours. The trend is accelerating rapidly, with one provider reporting a minimum of one new brand launch per day.

Jul 1, 2026 1 source